negative regulation of lipid biosynthetic process
Definition
Target type: biologicalprocess
Any process that stops, prevents, or reduces the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of lipids. [GOC:ai]
Negative regulation of lipid biosynthetic process refers to the cellular mechanisms that decrease the rate or extent of lipid synthesis. Lipids, including fats, oils, waxes, phospholipids, and steroids, are essential components of cell membranes, energy storage, and signaling molecules. Their synthesis is tightly regulated to maintain cellular homeostasis and respond to changes in environmental conditions.
This regulation involves a complex interplay of various factors:
**1. Transcriptional Control:**
* **Transcription factors:** Specific proteins bind to DNA sequences near lipid biosynthetic genes to either activate or repress their transcription, modulating the production of enzymes involved in lipid synthesis.
* **MicroRNAs:** Small RNA molecules can target messenger RNA (mRNA) transcripts of lipid biosynthetic genes, inhibiting their translation and reducing the production of enzymes.
**2. Post-Transcriptional Control:**
* **mRNA stability:** The lifetime of mRNA transcripts can be regulated, affecting the availability of templates for protein synthesis.
* **Protein translation:** The process of translating mRNA into proteins can be regulated, affecting the production of enzymes.
**3. Enzyme Activity Regulation:**
* **Allosteric regulation:** Enzymes can be activated or inhibited by binding of specific molecules at sites other than the active site.
* **Feedback inhibition:** The end product of a metabolic pathway can inhibit the activity of an early enzyme in the pathway, preventing overproduction.
* **Protein phosphorylation:** Adding or removing phosphate groups can alter enzyme activity, affecting lipid biosynthesis.
**4. Lipid Degradation and Recycling:**
* **Lipases:** Enzymes that break down lipids into smaller units can reduce the overall lipid content.
* **Recycling pathways:** Cells can utilize existing lipid components to synthesize new lipids, reducing the need for de novo synthesis.
**5. Hormonal Regulation:**
* **Insulin:** This hormone promotes lipid synthesis, while its absence or dysfunction can lead to reduced lipid biosynthesis.
* **Glucagon:** This hormone promotes lipid breakdown, counteracting the effects of insulin.
**6. Environmental Factors:**
* **Diet:** The availability of dietary lipids can influence the rate of lipid synthesis.
* **Stress:** Stress hormones can trigger the breakdown of lipids for energy production, reducing lipid biosynthesis.
Overall, negative regulation of lipid biosynthetic process is a crucial mechanism that maintains lipid homeostasis, ensuring appropriate lipid levels within the cell. This process is essential for normal cellular function and contributes to overall organismal health.'
"
Proteins (1)
Protein | Definition | Taxonomy |
---|---|---|
G-protein coupled estrogen receptor 1 | A G-protein coupled estrogen receptor 1 that is encoded in the genome of human. [PRO:WCB, UniProtKB:Q99527] | Homo sapiens (human) |
Compounds (1)
Compound | Definition | Classes | Roles |
---|---|---|---|
1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3h-cyclopenta(c)quinolin-8-yl)ethanone | 1-(4-(6-bromobenzo(1,3)dioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta(c)quinolin-8-yl)ethanone: G-1 was able to induce both c-fos expression and proliferation in the ERalpha-negative/GPR30-positive SKBR3 breast cancer cells, the requirement for ERalpha expression in GPR30/EGFR signaling may depend on the specific cellular context of different tumor types | agonist |